Cellerant Therapeutics Employee Directory
Biotechnology ResearchUnited States11-50 Employees
Cellerant Therapeutics is a United States-based clinical-stage biotechnology company focused on regulating the hematopoietic system—the process by which blood cells are formed. It develops human stem cell and antibody therapies for oncology applications and blood-related disorders, with the aim of addressing diseases through cellular and immune-based approaches. The lead product, CLT-008, is in two Phase 1 trials in patients with hematological malignancies. Additionally, the company runs a Cancer Stem Cell antibody discovery program focused on acute myeloid leukemia, multiple myeloma, and myelodysplastic syndrome. With a small, research-oriented footprint, it operates within the biotechnology research sector to advance early-stage therapies toward clinical testing.